Lista de obras -

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

artículo científico publicado en 2008

Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening.

artículo científico publicado en 2015

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden

artículo científico publicado en 2005

Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

artículo científico publicado en 2013

Effects of surgeon variability on oncologic and functional outcomes in a population-based setting

artículo científico publicado en 2014

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

artículo científico publicado en 2016

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

artículo científico publicado en 2011

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

artículo científico publicado en 2012

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening

artículo científico publicado en 2003

How badly did it hit? Self-assessed emotional shock upon prostate cancer diagnosis and psychological well-being: a follow-up at 3, 12, and 24 months after surgery

artículo científico publicado en 2017

Impact of cause of death adjudication on the results of the European prostate cancer screening trial.

artículo científico publicado en 2016

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

artículo científico publicado en 2010

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

artículo científico publicado en 2013

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

artículo científico publicado en 2011

Increase in percent free prostate-specific antigen in men with chronic kidney disease

artículo científico publicado en 2008

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study

artículo científico publicado en 2005

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.

artículo científico publicado en 2014

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

artículo científico publicado en 2010

Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study

artículo científico publicado en 2013

Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy

artículo científico publicado en 2009

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial

artículo científico publicado en 2002

Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review

artículo científico publicado en 2014

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2015

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

artículo científico publicado en 2010

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study

artículo científico publicado en 2010

Overdetection in screening for prostate cancer

artículo científico publicado en 2014

Prediction of prostate cancer in unscreened men: external validation of a risk calculator

artículo científico publicado en 2010

Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPRO.

artículo científico publicado en 2016

Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above

artículo científico publicado en 2016

Prostate Cancer Grading, Time To Go Back To the Future

artículo científico publicado en 2020

Prostate biopsy and anaesthesia: an overview

artículo científico publicado en 2005

Prostate cancer mortality in areas with high and low prostate cancer incidence

artículo científico publicado en 2014

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

artículo científico publicado en 2009

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

artículo científico publicado en 2012

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy

artículo científico publicado en 2010

Prostate-cancer mortality at 11 years of follow-up

artículo científico publicado en 2012

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

artículo científico publicado en 2009

Quality-of-life effects of prostate-specific antigen screening.

artículo científico publicado en 2012

Radical retropubic prostatectomy: A review of outcomes and side-effects ⬇️

artículo científico publicado el 1 de junio de 2011

Rehospitalization after radical prostatectomy in a nationwide, population based study

artículo científico

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

artículo científico

Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.

artículo científico publicado en 2015

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

artículo científico publicado en 2014

Screening and prostate-cancer mortality in a randomized European study

artículo científico publicado en 2009

The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer.

artículo científico publicado en 2015

The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival

artículo científico publicado en 2005

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group

artículo científico publicado en 2010

Lista de obras de

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening.

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden

Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

Effects of surgeon variability on oncologic and functional outcomes in a population-based setting

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening

How badly did it hit? Self-assessed emotional shock upon prostate cancer diagnosis and psychological well-being: a follow-up at 3, 12, and 24 months after surgery

Impact of cause of death adjudication on the results of the European prostate cancer screening trial.

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Increase in percent free prostate-specific antigen in men with chronic kidney disease

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study

Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial

Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study

Overdetection in screening for prostate cancer

Prediction of prostate cancer in unscreened men: external validation of a risk calculator

Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPRO.

Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above

Prostate Cancer Grading, Time To Go Back To the Future

Prostate biopsy and anaesthesia: an overview

Prostate cancer mortality in areas with high and low prostate cancer incidence

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy

Prostate-cancer mortality at 11 years of follow-up

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

Quality-of-life effects of prostate-specific antigen screening.

Radical retropubic prostatectomy: A review of outcomes and side-effects ⬇️

Rehospitalization after radical prostatectomy in a nationwide, population based study

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Screening and prostate-cancer mortality in a randomized European study

The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer.

The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group